How can the VoxNeuro Cognitive Health Assessment™ help with COVID-19 recovery?

Neurological consequences of COVID-19 are being reported in 36*-84%** of COVID-19 patients. Why such a big percentage range? Because the tools being used in the majority of clinics and hospitals to confirm the presence of neurological consequences are subjective – based on patient self-reporting or observable symptoms.

VoxNeuro’s technology can support healthcare systems to accurately measure the cognitive neurological consequences of COVID-19, and provide actionable insights that help inform clinical decisions by healthcare providers.

Learn more about the neurological consequences of COVID-19.

*Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., . . . Hu, B. (2020). Neurologic manifestations of hospitalized patients With Coronavirus DISEASE 2019 IN WUHAN, CHINA. JAMA Neurology, 77(6), 683. doi:10.1001/jamaneurol.2020.1127
**Ellul, M. A., Benjamin, L., Singh, B., Lant, S., Michael, B. D., Easton, A., . . . Solomon, T. (2020). Neurological associations of covid-19. The Lancet Neurology, 19(9), 767-783. doi:10.1016/s1474-4422(20)30221-0